Skip to main content
. 2020 Feb 13;15(2):e0228996. doi: 10.1371/journal.pone.0228996

Fig 4. Hematology parameter changes in DFMO- and HYD-treated groups in vivo.

Fig 4

Graphs showing the hematocrit (HCT) (A), red blood cells (RBCs) (B), and hemoglobin (HGB) (C) changes in treated mice compared to the infected-untreated mice. Asterisks (*) show significant variation (P < 0.05) between drug-treated and positive groups. The arrow shows 5 successive days of drug administration starting from day 4 to 8 p.i.